PSIL ETF

$25.41
Screen 5,700+ ETFsFind similar ETFs with lower fees
Showing 10 of 31 holdings(as of Jun 30, 2026)Top 10 Weight: 70.30%
#TickerNameWeightSharesMkt ValueShare ChgPROSectorPROIndustryPRO
1ATAI:MUAtai Life Sciences BV14.08%958,592$6.88M-UnknownUnknown
2DFTX:CADefinium Therapeutics Inc.11.89%134,624$5.81M-UnknownUnknown
3CMPSCompass Pathways Plc Adr9.70%421,139$4.74MProProPro
4NRXPNRX Pharmaceuticals Inc.5.61%731,055$2.74MProProPro
5CYBN:CACybin Inc Common Stock5.31%340,438$2.59MProProPro
6RLMDRelmada Therapeutics Inc Common Stock5.16%486,871$2.52MProProPro
7NBIXNeurocrine Biosciences Inc4.88%13,583$2.39MProProPro
8GHRSGh Research Plc4.66%83,467$2.28MProProPro
9ABBVAbbvie Inc Health Care4.53%8,538$2.21MProProPro
10ANROAlto Neuroscience, Inc., Series C4.48%81,784$2.19MProProPro
See the other 21 holdings of PSIL
Every position with sector, industry and share changes, as reported Jun 30, 2026.
Get FundXLS Pro: $29/moFirst 500 subscribers, then $49/mo. Cancel anytime.

Top Holdings Themes

BiotechnologyPharmaceuticalsDigital HealthBiotechnology ToolsOncologyImmunologySupply ChainInfrastructureMedical Devices

PSIL ETF Top Holdings

PSIL holdings top 10 positions. The top 10 holdings account for 70.3% of the fund, led by Atai Life Sciences BV at 14.1%, Definium Therapeutics Inc. at 11.9%, Compass Pathways Plc Adr at 9.7%.

PSIL portfolio concentration is relatively high, with the top 10 representing 70.3% of total assets. The largest sector exposure is Health Care at 55.6%.

PSIL sector allocation provides a detailed breakdown. PSIL overlap tool shows how holdings compare to other funds in your portfolio.

Compare PSIL

PSIL vs SPYPSIL vs QQQPSIL vs VOOPSIL vs VTIPSIL vs IVVPSIL vs SCHDPSIL vs VYMPSIL vs VXUS
Showing 10 of 31 holdingsTop 10 Weight: 70.30%
#TickerNameIndustryWeightAllocation
1ATAI:MUAtai Life Sciences BVUnknown14.08%
2DFTX:CADefinium Therapeutics Inc.Unknown11.89%
3CMPSCompass Pathways Plc AdrHealth Care9.70%
4NRXPNRX Pharmaceuticals Inc.Unknown5.61%
5CYBN:CACybin Inc Common StockHealth Care5.31%
6RLMDRelmada Therapeutics Inc Common StockHealth Care5.16%
7NBIXNeurocrine Biosciences IncHealth Care4.88%
8GHRSGh Research PlcHealth Care4.66%
9ABBVAbbvie Inc Health CareHealth Care4.53%
10ANROAlto Neuroscience, Inc., Series CHealth Care4.48%
Want to see all 31 holdings?

Holdings Distribution

Loading chart...